Science|Business Reporting

The EMA says Amsterdam Molecular Therapeutics’ Glybera for treating a serious enzyme deficiency, is not ready for approval

Stephan Tanda, a director of DSM, the Dutch life sciences company, has been appointed to head the pan-European industry body

Máire Geoghegan-Quinn, Research, Innovation and Science Commissioner has announced the winner of the competition to name the future EU funding programme for research and innovation

The multinational company is accused of failing to market a device developed by the UK Ministry of Defence for diagnosing infections of the superbug, going against the terms agreed when 3M acquired the device

The pharmaceutical sector launched a Framework for Action to tackle non-communicable diseases including cardiovascular disease, cancer, diabetes and chronic respiratory diseases that are posing a threat to public health, and public and private finances worldwide.

By focussing in on the research function, international university rankings are giving a skewed picture and pushing investments towards things that improve an institution’s position, and away from core activities like teaching.

The latest Eurobarometer report shows citizens have concerns about the security and privacy of their data online. This is holding back the development of Europe’s single digital market, says the Commission

US/European move to put more weight behind moves to improve drug development processes and increase’s R&D productivity in the pharmaceutical industry

Following the deadly outbreak of E. coli infections in Germany, scientists in Saarbruecken are providing free access to the pathogen’s genetic regulation data, to spur research into new antibiotics

The Helmholtz is to lead a major investigation into the sustainable development of rice ecosystems in Southeast Asia involving 22 research institutions